English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/108793
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs

AutorCanals, Albert ; Purciolas, Mònica; Aymamí, Joan; Coll, Miquel
Palabras claveanticancer drugs
intercalating agent
ellipticine derivative
ellipticine
DNA
antineoplastic agent
DNA binding
drug design
intercalators
ellipticine
Fecha de publicación4-jul-2005
EditorBlackwell Publishing
CitaciónActa Crystallographica Section D: Biological Crystallography 61(7): 1009-1012 (2005)
ResumenEllipticine is a natural plant product that has been found to be a powerful anticancer drug. Although still unclear, its mechanism of action is considered to be mainly based on DNA intercalation and/or the inhibition of topoisomerase II. Many experimental data suggest an intercalation based on stacking interactions along the major base-pair axis, but alternative binding modes have been proposed, in particular for ellipticine derivatives. The 1.5 Å resolution structure of ellipticine complexed to a 6 bp oligonucleotide unveils its mode of binding and enables a detailed analysis of the distorting effects of the drug on the DNA. © 2005 International Union of Crystallography - all rights reserved.
Versión del editorhttp://dx.doi.org/10.1107/S0907444905015404
URIhttp://hdl.handle.net/10261/108793
DOI10.1107/S0907444905015404
Identificadoresdoi: 10.1107/S0907444905015404
issn: 0907-4449
Aparece en las colecciones: (IBMB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Canals-Acta-Cryst-D-2005-v61-n7-p1009.pdf663,97 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.